| Literature DB >> 27441036 |
Xiangyou Liu1, Gary B Braun1, Haizheng Zhong2, David J Hall3, Wenlong Han1, Mingde Qin4, Chuanzhen Zhao2, Meina Wang5, Zhi-Gang She1, Chuanbao Cao5, Michael J Sailor4, William B Stallcup1, Erkki Ruoslahti1, Kazuki N Sugahara1.
Abstract
The rapid development of fluorescence imaging technologies requires concurrent improvements in the performance of fluorescent probes. Quantum dots have been extensively used as an imaging probe in various research areas because of their inherent advantages based on unique optical and electronic properties. However, their clinical translation has been limited by the potential toxicity especially from cadmium. Here, a versatile bioimaging probe is developed by using highly luminescent cadmium-free CuInSe2/ZnS core/shell quantum dots conjugated with CGKRK (Cys-Gly-Lys-Arg-Lys) tumor-targeting peptides. This probe exhibits excellent photostability, reasonably long circulation time, minimal toxicity, and strong tumor-specific homing property. The most important feature of this probe is that it shows distinctive versatility in tumor-targeted multimodal imaging including near-infrared, time-gated, and two-photon imaging in different tumor models. In a glioblastoma mouse model, the targeted probe clearly denotes tumor boundaries and positively labels a population of diffusely infiltrating tumor cells, suggesting its utility in precise tumor detection during surgery. This work lays a foundation for potential clinical translation of the probe.Entities:
Year: 2015 PMID: 27441036 PMCID: PMC4948596 DOI: 10.1002/adfm.201503453
Source DB: PubMed Journal: Adv Funct Mater ISSN: 1616-301X Impact factor: 18.808